About
Radiopharmaceuticals
Areas of Focus
Categories
DiagnosticsRadiopharmaceuticals
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
79
By Phase
PHASE2: 2PHASE3: 1PHASE1/PHASE2: 1EARLY_PHASE1: 1
By Status
TERMINATED: 2RECRUITING: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06478875Collaborator
Evaluation of [68Ga]Ga-PentixaFor PET Imaging for the Identification of Unilateral Adrenal Secretion of ALdosterON in Patients With Primary Aldosteronism
PHASE2Not yet recruiting
20 participants
Started: Jun 30, 2024 · Completed: Jun 30, 2027
NCT06125028Lead Sponsor
[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma
PHASE3Terminated
13 participants
Started: May 20, 2024 · Completed: Jul 18, 2025
NCT06132737Lead Sponsor
[90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients
PHASE1/PHASE2Recruiting
15 participants
Started: Nov 7, 2023 · Completed: Mar 26, 2028
NCT05222269Lead Sponsor
[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
PHASE2Terminated
1 participants
Started: Oct 5, 2022 · Completed: Jan 25, 2023
NCT05093335Collaborator
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
EARLY_PHASE1Recruiting
30 participants
Started: Oct 1, 2021 · Completed: Oct 31, 2026
Locations (1)
Headquarters
Würzburg, Germany
Map
Loading map...